Urinary adiponectin as a new diagnostic index for chronic kidney disease due to diabetic nephropathy.

Shinnosuke YamakadoHiroki ChoMikio InadaMika MorikawaYong-Huang JiangKenji SaitoKazunari NakaishiSatoshi WatabeHitomi TakagiMugiho KanedaAkira NakatsumaMasaki NinomiyaHitomi ImachiTakeshi AraiTakuo YoshimotoKoji MuraoJyun-Hao ChangShih-Min ChenYi-Chen ShihMin-Jing ZengLiang-Yin Ke Chu-Huang ChenTeruki YoshimuraToshiaki MiuraEtsuro Ito

Published in: BMJ open diabetes research & care (2019)

Our new assay showed that urinary adiponectin could be a new diagnostic index for CKD. This assay is a non-invasive test using only urine, thus reducing the patient burden.

Keyphrases

chronic kidney disease
diabetic nephropathy
end stage renal disease
high throughput
metabolic syndrome
insulin resistance
case report
risk factors
type diabetes
adipose tissue